Description:
Biostar Pharmaceuticals, Inc. (Biostar), through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People’s Republic of China. The Company’s product, Xin Ao Xing Oleanolic Acid Capsule is an over-the- counter (OTC) medicine for chronic hepatitis B. Its product line also includes two other OTC products and two prescription-based pharmaceuticals. In June 2009, the Company launched its Internet-based China Hepatitis Internet Hospital (CHIH).

Officers and Directors:
Liang Qiao M.D. Chairman of the Board, Chief Executive Officer, Secretary
Age: 49
Wenhui Qiao President, Director
Age: 40
Chuen Huei Lee Chief Financial Officer
Age: 39
Toshihiro Komoike Vice President, Director
Age: 57
Isao Arimoto Vice President, Director
Age: 61
Shyh-Jing Chiang Director
Age: 49
Trevor Roy Director
Age: 63
Hin Shun Cheung Director

Contact:
1211 West 22nd Street, Suite 615
Oak Brook, IL 60523
United States - Map
+1-630-9280869 (Phone)
+1-630-2036088 (Fax)